Welcome to our dedicated page for Manulife Finl news (Ticker: MFC), a resource for investors and traders seeking the latest updates and insights on Manulife Finl stock.
Manulife Financial Corporation reports developments across its international insurance, financial advice, health solutions, and wealth and asset management businesses. The company operates as Manulife in Canada and Asia and primarily as John Hancock in the United States, with news commonly covering insurance distribution, retirement services, investment solutions, customer health and longevity initiatives, and community programs.
Recurring updates also include quarterly and annual results, dividend announcements, annual meeting materials, management information circulars, shareholder voting matters, executive conference participation, and capital actions involving common and preferred shares. News from John Hancock adds detail on U.S. insurance sales, executive benefits, the John Hancock Vitality program, and longevity-focused research and planning tools.
Manulife (NYSE:MFC), in partnership with UpLink and the World Economic Forum's Centre for Financial and Monetary Systems, launched the Shaping Canada's Longevity Advantage innovation challenge on April 22, 2026.
The initiative seeks practical solutions for financial resilience, healthy aging, and social connection to help Canadians live longer, healthier, and more connected lives.
John Hancock (TSX/NYSE: MFC) launched a personalized Longevity Preparedness assessment tool on April 14, 2026, developed with MIT AgeLab to translate the 2025 Longevity Preparedness Index into individualized scores and actions.
The interactive tool rates users across eight domains—health, finance, care, home, daily activities, community, life transitions, and social connection—producing overall and domain scores from 0–100 and offering tailored, actionable insights to improve readiness for longer lifespans.
John Hancock (NYSE:MFC) held its third Longer. Healthier. Better. Symposium in Boston on April 13, 2026, convening leaders across science, medicine, policy and athletics to discuss longevity advances.
The company announced new John Hancock Vitality cardiac offerings—discounted in-home AED access via GoRescue and a Garmin Index BPM blood pressure monitor offer—to expand prevention and home-based response for members.
Manulife (TSX/NYSE/PSE: MFC; SEHK: 945) has posted its 2026 Management Information Circular and 2025 Annual Report for shareholders. The circular covers the annual meeting logistics, director elections and auditor appointment. The meeting is set for May 14, 2026 at 11:00 a.m. ET in person and by live webcast.
Documents are available online at manulife.com/annualmeeting, SEDAR+, EDGAR and the transfer agent site; paper copies can be requested via TSX Trust.
Manulife (TSX/NYSE/PSE: MFC; SEHK: 945) announced that CFO Colin Simpson will take part in a fireside chat at National Bank Financial's 24th Annual Financial Services Conference on Tuesday, March 24, 2026 at 9:00 a.m. ET. A live webcast and a replay will be available on Manulife's investor website for 90 days.
Manulife (NYSE:MFC) selected Akka to operationalize agentic AI within its enterprise AI platform, aiming to strengthen security, reliability, and performance as the platform expands across the business.
The platform is in beta and Manulife expects AI to generate $1 billion+ of enterprise value by 2027, with roughly one‑fifth from efficiency gains.
Manulife Investment Management (MFC) appointed Liam Spillane as Head of Emerging Markets Fixed Income and Senior Portfolio Manager, Emerging Markets Debt effective January 26, 2026. Based in London, he oversees the global Emerging Markets Fixed Income organisation and leads growth and investment performance across the firm's strategies.
Mr. Spillane brings over 30 years of industry experience, including more than 12 years at Aviva Investors where he last served as Head of Emerging Markets Debt.
Manulife (TSX/NYSE: MFC) received TSX approval for a normal course issuer bid to buy up to 42 million common shares (about 2.5% of issued shares). The NCIB runs from Feb 24, 2026 to Feb 23, 2027, with daily purchases capped at 1,483,481 shares (25% of six‑month ADTV). All shares acquired will be cancelled and purchases remain subject to regulatory and capital requirements.
Manulife (TSX/NYSE/PSE: MFC; SEHK: 945) filed its 2025 audited annual financial statements for the year ended December 31, 2025 and the related MD&A with securities regulators, including the Canadian Securities Administrators and the U.S. SEC on Form 40-F.
According to the company, these documents are available online at manulife.com/en/investors/results-and-reports and shareholders can request a free hard copy via the company's website.
Manulife (MFC) announced a 10.2% increase to its quarterly common shareholders' dividend, rising by 4.5 cents to $0.485 per share. The dividend is payable on and after March 19, 2026 to shareholders of record at the close of business on February 25, 2026.
For the Canadian and U.S. Dividend Reinvestment and Share Purchase Plans, the company will buy common shares on the open market to satisfy reinvested dividends and optional cash purchases; there are no applicable discounts and purchase price will be the average actual cost to buy the shares.